Capital Bank & Trust’s ResMed RMD Stock Holding History

Capital Bank & Trust’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-19	Closed	-$3K	–	773
2019 Q4	$3K	Hold	19	–	–	﹤0.01%	652
2019 Q3	$3K	Buy	+19	New	+$2.49K	﹤0.01%	683

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital Bank & Trust's RMD Position: Q1 2020 in Review

Capital Bank & Trust sold out of ResMed (RMD) in Q1 2020, closing a stake of 19 shares — an estimated $3K sold.

Capital Bank & Trust first reported a position in RMD in Q3 2019 and held it in 2 quarters. The position peaked at $3K in Q4 2019. 584 funds tracked by Wall St. Rank hold RMD as of Q1 2020.

Capital Bank & Trust reported no remaining ResMed position as of Q1 2020 after selling out during the quarter.
Capital Bank & Trust sold 19 ResMed shares in Q1 2020, an estimated $3K.
Capital Bank & Trust first reported a position in ResMed in Q3 2019 and held it in 2 quarters.
Capital Bank & Trust's ResMed position peaked at $3K in Q4 2019.
584 funds tracked by Wall St. Rank held ResMed as of Q1 2020.

Based on Capital Bank & Trust's 13F filing for Q1 2020, filed 15 May 2020.